161
Bibliografia
1.
Fante RJ, Durairaj, VD, Oliver SC. Diabetic retinopathy: An update on
treatment. Am. J. Med., 2010, 123(3), 213-216.
2.
Campochiaro, PA, Hafiz G, Shah SM, Bloom S, Brown DM, Busquets M,
Ciulla T, Feiner L, Sabates N, Billman K, Kapik B, Green K, Kane F. Sus-
tained ocular delivery of fluocinolone acetonide by an intravitreal insert.
Ophthalmology, 2010, 117(7),1393-1399 e3.
3.
Kozak I; Oster SF; Cortes MA; Dowell D; Hartmann K; Kim JS; Free-
man WR. Laser photocoagulator NAVILAS.Ophthalmology. 2011;
118(6):1119-24 (
ISSN: 1549-4713).
4.
Wong TY, Simo R, Mitchel P. Fenofibrate – A Potential Systemic Treatment
for Diabetic Retinopathy?. Am J Ophthalmol.2012;154:6–12.
5.
Hattori T, Matsubara A, Taniguchi K, Ogura Y. Aldose reductase inhibitor
fidarestat attenuates leukocyte-endothelial interactions in experimental
diabetic rat retina in vivo. Curr. Eye Res., 2010, 35(2),146-154.
6.
Shen X, Zhong Y, Xie B, Cheng Y, Jiao Q. Pigment epithelium derived
factor as an anti-inflammatory factor against decrease of glutamine syn-
thetase expression in retinal Muller cells under high glucose conditions.
Graef. Arch. Clin. Exp. Ophthalmol., 2010, 248(8),1127-1136.